Navigation Links
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
Date:3/3/2008

-party relationships and revenues; dependence on third parties for supplies, particularly for histrelin, manufacturing, marketing, and clinical trials; risks associated with being a manufacturer of some of our products; risks associated with contractual agreements, particularly for the manufacture and co-promotion of SANCTURA and SANCTURA XR and the manufacture of NEBIDO, VANTAS, SUPPRELIN LA and VALSTAR; reliance on intellectual property and having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement policies and/or rates for SANCTURA, SANCTURA XR, VANTAS, SUPPRELIN LA, DELATESTRYL and any future products; acceptance by the healthcare community of our approved products and product candidates; uncertainties relating to clinical trials, regulatory approval and commercialization of our products, particularly SANCTURA XR, NEBIDO, and VALSTAR; product liability and insurance uncertainties; risks relating to the Redux-related litigation; need for additional funds and corporate partners, including for the development of our products; history of operating losses and expectation of future losses; uncertainties relating to controls over financial reporting; difficulties in managing our growth; valuation of our Common Stock; risks related to repayment of debts; risks related to increased leverage; general worldwide economic conditions and related uncertainties; and other risks. Indevus undertakes no obligation to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise.

Contact:

For Indevus:

Michael W. Rogers

Executive Vice President and CFO

(781) 861-8444

Brooke D. Wagner

Vice President, Corporate Communications

(781) 402-3410


'/>"/>
SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
2. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
3. Indevus Pharmaceuticals To Present at RBC Capital Markets Conference
4. Indevus To Announce First Quarter Fiscal 2008 Financial Results On Thursday, February 7, 2008
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... robust distribution channels and efficient customer and technical support services to promote LodonalTM ... approved 90-day Bridging trial evaluating the efficacy and safety of the product. , ...
(Date:9/2/2015)... ... September 03, 2015 , ... Leah Binder, MA, MGA, ... influential leaders in healthcare, will offer the keynote address at the upcoming meeting ... 2015, in Palm Harbor, Florida, at the Innisbrook Resort and Golf Club. For ...
(Date:9/2/2015)... Washington, DC (PRWEB) , ... September 03, 2015 ... ... stacks of nominations to determine who among America’s policymakers, public servants, activists, corporate ... on the nation’s health care. This year, that process led the magazine to ...
(Date:9/2/2015)... (PRWEB) , ... September 02, ... ... the 2015 Warrior-Family Symposium (WFS), cosponsored by the Military Officers Association of ... During the event, "Our Nation's Military: Caring For Our Own,” expert panelists ...
(Date:9/2/2015)... Los Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... working to expand their fleet of truly superb luxury vehicles based on which of ... are pleased to announce the latest step forward in pursuit of this goal: a ...
Breaking Medicine News(10 mins):Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2
... with demand. Two experts in this weeks BMJ debate whether ... there is evidence to the contrary is the answer. ... support organ donation, yet only 23% have registered their wish ... at the British Medical Association. ,Research indicates that ...
... robotic technology may improve survival rates for prostate ... Thomas Jefferson University Hospitals multidisciplinary Genitourinary (GU) cancer ... 21, 2007 at the annual American Urological Society ... that performing a laparoscopic radical prostatectomy (LRP) with ...
... 10-fold over the past 40 years in England, owing to ... finds research published ahead of print in the British ... wide geographical variation in rates suggest that the NHS is ... and training, say the authors. ,The research team ...
... Researchers at Jefferson Medical College have shown that capsule ... small bowel Crohns disease in children. The technology has ... more than five years to diagnose unexplained abdominal bleeding ... is not much bigger than a vitamin pill and ...
... In a move to improve global public health, Weill ... heart disease drug onto the World Health Organization's ... guideline for developing countries to choose which high-priority drugs ... ,Students from Weill Cornell's chapter of Universities Allied for ...
... young to speak or crawl, but they can certainly tell ... with only visual cues. ,Researcher Whitney Weikum ... able to discern when a different language is spoken by ... face movements. ,The findings suggest that babies growing ...
Cached Medicine News:Health News:Is Presumed Consent the Answer to Organ Shortages? 2Health News:Robotic Surgery May Improve Survival Rate For Prostate Cancer Patients 2Health News:NHS Oversupplied With Cataract Surgery, Say Doctors 2Health News:Medical College Students Help Change Global Health Policy 2Health News:Even at Four Months, Babies can Tell When Speakers Switch Languages 2
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 /PRNewswire/ ... devices are artificial implants used to replace, augment, ... used in a wide range of applications including ... These implants are made of different materials such ... analysts forecast the global implantable medical devices market ...
(Date:9/2/2015)... -- About Neuroendovascular Coil A ... and ruptured brain aneurysm (a weakened area in ... as an endovascular coiling or endovascular embolization. During ... flow in an aneurysm. The endovascular coiling treatment ... interventional neuroradiologist using fluoroscopic imaging guidance. Neuroendovascular coils ...
(Date:9/2/2015)... -- About Chronic Lymphocytic Leukemia Chronic ... production of lymphocytes. It has been observed that the ... to other parts of the body. This leukemia is ... buildup of the cancerous cells. During the course of ... and lymph nodes. The course of the disease is ...
Breaking Medicine Technology:Global Implantable Medical Devices Market 2015-2019 2Global Neuroendovascular Coil Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3
...  Premier Research Group announces the appointment of Susan ... Vice President, Clinical Development. In this position, Dr. ... developing the company,s clinical trial management services provided ... industry knowledge and proven leadership skills will be ...
...  LIQUENT, Inc. the global leader in regulatory information ... LIQUENT,s XEVMPD Educational Series and Data Assessment tool. ... the July 2012 deadline for submitting product information ... LIQUENT,s XEVMPD Educational Series is ...
Cached Medicine Technology:Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development 2LIQUENT Announces XEVMPD Educational Series and Data Assessment Tool 2
Diareader ELX800G...
Plate Reader is an eight channel photometer for the sequential and simultaneous reading of micro-plate strips with 96 wells. High technology, user friendly, powerful and reliable....
... certified microstrip reader. Stat fax 303 ... to use with step-by-step prompting and ... other programming enhancements. On-board software calculates ... & a variety of cutoff options. ...
Iems Incubator/Shaker expansion module for 2 module incubator/shaker. high performance microplate incubator and orbital shaker. It's superior temperature control and efficient orbital shaking reduce ...
Medicine Products: